City Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate
City Therapeutics, Inc. Common Stock cash flow reinvestment rate. City Therapeutics, Inc. Common Stock (CTY) has a Cash Flow Reinvestment Rate of 0.41x as of June 2020, reinvesting $289.00 Million (capex $289.00 Million ) from operating cash flow of $699.00 Million. Explore City Therapeutics, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of City Therapeutics, Inc. Common Stock (2005–2019)
Cash flow reinvestment rate of City Therapeutics, Inc. Common Stock from 2005 to 2019. Historical reinvestment intensity for City Therapeutics, Inc. Common Stock across 15 annual periods. Explore City Therapeutics, Inc. Common Stock (CTY) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
City Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate by Year (2005–2019)
City Therapeutics, Inc. Common Stock cash flow reinvestment rate by year from 2005 to 2019. Year-by-year capital reinvestment analysis for City Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see City Therapeutics, Inc. Common Stock (CTY) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.32x | $1.05 Billion | $3.33 Billion | $1.05 Billion | ▲ +15.4% |
| 2018 | 0.27x | $1.04 Billion | $3.79 Billion | $1.04 Billion | ▼ -49.7% |
| 2017 | 0.55x | $1.33 Billion | $2.44 Billion | $1.33 Billion | ▲ +14.9% |
| 2016 | 0.47x | $1.26 Billion | $2.65 Billion | $1.26 Billion | ▼ -1.4% |
| 2015 | 0.48x | $1.25 Billion | $2.59 Billion | $1.25 Billion | ▲ +15.7% |
| 2014 | 0.42x | $1.17 Billion | $2.80 Billion | $1.17 Billion | ▼ -10.7% |
| 2013 | 0.47x | $1.26 Billion | $2.71 Billion | $1.26 Billion | ▲ +2.1% |
| 2012 | 0.46x | $1.27 Billion | $2.77 Billion | $1.27 Billion | ▼ -3.0% |
| 2011 | 0.47x | $1.04 Billion | $2.20 Billion | $1.04 Billion | ▲ +22.8% |
| 2010 | 0.38x | $1.24 Billion | $3.23 Billion | $1.24 Billion | ▲ +9.8% |
| 2009 | 0.35x | $1.11 Billion | $3.17 Billion | $1.11 Billion | ▼ -13.5% |
| 2008 | 0.40x | $1.40 Billion | $3.48 Billion | $1.40 Billion | ▲ +26.9% |
| 2007 | 0.32x | $1.04 Billion | $3.26 Billion | $1.04 Billion | ▼ -16.1% |
| 2006 | 0.38x | $1.19 Billion | $3.13 Billion | $1.19 Billion | ▲ +5.1% |
| 2005 | 0.36x | $1.23 Billion | $3.42 Billion | $1.23 Billion | — |